References
- Quan TM, Thao TTN, Duy NM, et al. Estimates of the global burden of Japanese encephalitis and the impact of vaccination from 2000-2015. Elife. 2020;9:e51027. doi:10.7554/eLife.51027
- Campbell GL, Hills SL, Fischer M, et al. Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ. 2011;89(10):774A–774E.
- Zheng Y, Li M, Wang H, et al. Japanese encephalitis and Japanese encephalitis virus in mainland China. Rev Med Virol. 2012;22(5):301–322. doi:10.1002/rmv.1710
- Pan XL, Liu H, Wang HY, et al. Emergence of genotype I of Japanese encephalitis virus as the dominant genotype in Asia. J Virol. 2011;85(19):9847–9853. doi:10.1128/JVI.00825-11
- Han N, Adams J, Chen P, et al. Comparison of genotypes I and III in Japanese encephalitis virus reveals distinct differences in their genetic and host diversity. J Virol. 2014;88(19):11469–11479. doi:10.1128/JVI.02050-14
- Sikazwe C, Neave MJ, Michie A, et al. Molecular detection and characterisation of the first Japanese encephalitis virus belonging to genotype IV acquired in Australia. PLoS Negl Trop Dis. 2022;16(11):e0010754. doi:10.1371/journal.pntd.0010754
- Howard-Jones AR, Pham D, Jeoffreys N, et al. Emerging genotype IV Japanese encephalitis virus outbreak in New South Wales, Australia. Viruses. 2022;14(9):1853. doi:10.3390/v14091853
- Li MH, Fu SH, Chen WX, et al. Genotype v Japanese encephalitis virus is emerging. PLoS Negl Trop Dis. 2011;5(7):e1231. doi:10.1371/journal.pntd.0001231
- Kim H, Cha G-W, Jeong YE, et al. Detection of Japanese encephalitis virus genotype V in culex orientalis and culex pipiens (diptera: culicidae) in Korea. PLoS One. 2015;10(2):e0116547. doi:10.1371/journal.pone.0116547
- Woo JH, Jeong YE, Jo JE, et al. Genetic characterization of Japanese encephalitis virus genotype 5 isolated from patient, South Korea, 2015. Emerg Infect Dis. 2020;26(5):1002–1006. doi:10.3201/eid2605.190977
- Lee AR, Song JM, Seo SU. Emerging Japanese encephalitis virus genotype V in Republic of Korea. J Microbiol Biotechnol. 2022;32(8):955–959. doi:10.4014/jmb.2207.07002
- Zhang W, Yin Q, Wang H, et al. The reemerging and outbreak of genotypes 4 and 5 of Japanese encephalitis virus. Front Cell Infect Microbiol. 2023;13:1292693. doi:10.3389/fcimb.2023.1292693
- Tajima S, Shibasaki K-i, Taniguchi S, et al. E and prM proteins of genotype V Japanese encephalitis virus are required for its increased virulence in mice. Heliyon. 2019;5(11):e02882. doi:10.1016/j.heliyon.2019.e02882
- Tajima S, Yagasaki K, Kotaki A, et al. In vitro growth, pathogenicity and serological characteristics of the Japanese encephalitis virus genotype V Muar strain. J Gen Virol. 2015;96(9):2661–2669. doi:10.1099/vir.0.000213
- Fernandez E, Kose N, Edeling MA, et al. Mouse and human monoclonal antibodies protect against infection by multiple genotypes of Japanese encephalitis virus. mBio. 2018;9(1):e00008-18. doi:10.1128/mBio.00008-18
- Erra EO, Askling HH, Yoksan S, et al. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study. Vaccine. 2013;32(1):119–123. doi:10.1016/j.vaccine.2013.10.055
- Erra EO, Askling HH, Yoksan S, et al. Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes. Clin Infect Dis. 2013;56(2):267–270. doi:10.1093/cid/cis883
- Tajima S, Taniguchi S, Nakayama E, et al. Immunogenicity and protective ability of genotype I-based recombinant Japanese encephalitis virus (JEV) with attenuation mutations in E protein against genotype V JEV. Vaccines (Basel). 2021;9(10):1077. doi:10.3390/vaccines9101077
- Honjo S, Masuda M, Ishikawa T. Effects of the Japanese encephalitis virus genotype V-derived Sub-viral particles on the immunogenicity of the vaccine characterized by a novel virus-like particle-based assay. Vaccines (Basel). 2019;7(3):81. doi:10.3390/vaccines7030081
- Cao L, Fu S, Gao X, et al. Low protective efficacy of the current Japanese encephalitis vaccine against the emerging genotype 5 Japanese encephalitis virus. PLoS Negl Trop Dis. 2016;10(5):e0004686. doi:10.1371/journal.pntd.0004686
- de Wispelaere M, Frenkiel MP, Desprès P. A Japanese encephalitis virus genotype 5 molecular clone is highly neuropathogenic in a mouse model: impact of the structural protein region on virulence. J Virol. 2015;89(11):5862–5875. doi:10.1128/JVI.00358-15
- Kim JD, Lee AR, Moon DH, et al. Efficacy of genotype-matched vaccine against re-emerging genotype V Japanese encephalitis virus. Emerg Microbes Infect. 2024;13(1):2343910. doi:10.1080/22221751.2024.2343910
- Seo MG, Lee HS, Yang SC, et al. National monitoring of mosquito populations and molecular analysis of flavivirus in the Republic of Korea in 2020. Microorganisms. 2021;9(10):2085. doi:10.3390/microorganisms9102085
- Ishikawa T, Abe M, Masuda M. Construction of an infectious molecular clone of Japanese encephalitis virus genotype V and its derivative subgenomic replicon capable of expressing a foreign gene. Virus Res. 2015;195:153–161. doi:10.1016/j.virusres.2014.10.010
- Zhang F, Luo J, Teng M, et al. Study on the Dynamic Proliferation of JEV in BHK-21 Cells. Intervirology. 2021;64(1):1–7. doi:10.1159/000510585
- Tajima S, Maeki T, Nakayama E, et al. Growth, pathogenesis, and serological characteristics of the Japanese encephalitis virus genotype IV recent strain 19CxBa-83-Cv. Viruses. 2023;15(1):239. doi:10.3390/v15010239
- Hsieh JT, St John AL. Japanese encephalitis virus and its mechanisms of neuroinvasion. PLoS Pathog. 2020;16(4):e1008260). doi:10.1371/journal.ppat.1008260
- Zhang L, Nan X, Zhou D, et al. Japanese encephalitis virus NS1 and NS1’ protein disrupts the blood-brain barrier through macrophage migration inhibitory factor-mediated autophagy. J Virol. 2024;98(5):e0011624. doi:10.1128/jvi.00116-24
- Grist JJ, Marro B, Lane TE. Neutrophils and viral-induced neurologic disease. Clin Immunol. 2018;189:52–56. doi:10.1016/j.clim.2016.05.009
- Terry RL, Getts DR, Deffrasnes C, et al. Inflammatory monocytes and the pathogenesis of viral encephalitis. J Neuroinflammation. 2012;9:270. doi:10.1186/1742-2094-9-270
- Yimyaem M, Jitobaom K, Auewarakul P. A small stretch of poor codon usage at the beginning of dengue virus open Reading frame may act as a translational checkpoint. BMC Res Notes. 2023;16(1):359. doi:10.1186/s13104-023-06615-5
- Hosseini Rad Sm A, McLellan AD. Implications of SARS-CoV-2 mutations for genomic RNA structure and host microRNA targeting. Int J Mol Sci. 2020;21(13):4807. doi:10.3390/ijms21134807
- Baranovskaya I, Sergeeva M, Fadeev A, et al. Changes in RNA secondary structure affect NS1 protein expression during early stage influenza virus infection. Virol J. 2019;16(1):162. doi:10.1186/s12985-019-1271-0
- Sanborn MA, Wuertz KM, Kim HC, et al. Metagenomic analysis reveals Culex mosquito virome diversity and Japanese encephalitis genotype V in the Republic of Korea. Mol Ecol. 2021;30(21):5470–5487. doi:10.1111/mec.16133
- Semple BD, Kossmann T, Morganti-Kossmann MC. Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J Cereb Blood Flow Metab. 2010;30(3):459–473. doi:10.1038/jcbfm.2009.240